This topic is empty. Viewing 0 reply threads Author Posts June 26, 2020 at 9:23 am #19828 MS News Today ModeratorParticipant A report details an RRMS patient on long-term Gilenya (fingolimod) use, who developed severe COVID-19 infection with lung involvement and recovered well. Read the full story here. What do you think of this news? Author Posts Viewing 0 reply threads You must be logged in to reply to this topic. Log In Username: Password: Keep me signed in Log in with Facebook or Log In